Nasdaq:US$14.54 (-0.06) | HKEX:HK$22.50 (-0.15) | AIM:£2.21 (-0.04)
搜索
新聞中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科學出版物 | 2010-10-16

ISSX 2011: Preclinical assessment of the absorption, distribution, metabolism and excretion of HMPL-013 (fruquintinib), a novel potent and specific VEGFR inhibitor